174 related articles for article (PubMed ID: 25062880)
1. Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival.
Xu YF; Lu Y; Cheng H; Shi S; Xu J; Long J; Liu L; Liu C; Yu X
Pancreatology; 2014; 14(4):295-301. PubMed ID: 25062880
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC).
Xiang ZJ; Hu T; Wang Y; Wang H; Xu L; Cui N
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510138
[TBL] [Abstract][Full Text] [Related]
3. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
4. Low intratumoral regulatory T cells and high peritumoral CD8(+) T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy.
Liu L; Zhao G; Wu W; Rong Y; Jin D; Wang D; Lou W; Qin X
Cancer Immunol Immunother; 2016 Jan; 65(1):73-82. PubMed ID: 26646849
[TBL] [Abstract][Full Text] [Related]
5. Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancer.
Liu C; Cheng H; Luo G; Lu Y; Jin K; Guo M; Ni Q; Yu X
Int J Oncol; 2017 Aug; 51(2):686-694. PubMed ID: 28714519
[TBL] [Abstract][Full Text] [Related]
6. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
[TBL] [Abstract][Full Text] [Related]
7. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
8. Circulating CD4+CD25+ regulatory T cells in patients with pancreatic cancer.
Yamamoto T; Yanagimoto H; Satoi S; Toyokawa H; Hirooka S; Yamaki S; Yui R; Yamao J; Kim S; Kwon AH
Pancreas; 2012 Apr; 41(3):409-15. PubMed ID: 22158072
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer.
Sierzega M; Lenart M; Rutkowska M; Surman M; Mytar B; Matyja A; Siedlar M; Kulig J
Ann Surg Oncol; 2017 Mar; 24(3):808-815. PubMed ID: 27770341
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer.
Qiu H; Xiao-Jun W; Zhi-Wei Z; Gong C; Guo-Qiang W; Li-Yi Z; Yuan-Fang L; Rajiv-Prasad K
Hepatogastroenterology; 2009; 56(94-95):1310-5. PubMed ID: 19950782
[TBL] [Abstract][Full Text] [Related]
12. [Changes of lymphocyte subsets in peripheral blood of patients with hepatitis C].
Wan H; Li Y; Yang N; Yuan W; Xie N; Wang D; Guo T; Mao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1058-61. PubMed ID: 25270208
[TBL] [Abstract][Full Text] [Related]
13. Monitoring and functional characterization of the lymphocytic compartment in pancreatic ductal adenocarcinoma patients.
Oberg HH; Grage-Griebenow E; Adam-Klages S; Jerg E; Peipp M; Kellner C; Petrick D; Gonnermann D; Freitag-Wolf S; Röcken C; Sebens T; Vogel I; Becker T; Ebsen M; Kabelitz D; Wesch D; Sebens S
Pancreatology; 2016; 16(6):1069-1079. PubMed ID: 27424476
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Treatment on Peripheral Blood Immune Cell Profile in Pancreatic Ductal Adenocarcinoma (PDAC).
Tulyte S; Characiejus D; Matuzeviciene R; Janiulioniene A; Radzevicius M; Zvirblis T; Sileikis A
Anticancer Res; 2022 Jun; 42(6):3067-3073. PubMed ID: 35641268
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of circulating T-lymphocyte subsets in advanced pancreatic cancer patients treated with mFOLFIRINOX or gemcitabine.
Tulyte S; Characiejus D; Matuzeviciene R; Janiulioniene A; Radzevicius M; Jasiunaite E; Zvirblis T; Sileikis A
Int Immunopharmacol; 2023 Feb; 115():109722. PubMed ID: 37724957
[TBL] [Abstract][Full Text] [Related]
16. Circulating lymphocyte subsets in pancreatic adenocarcinoma and their relationship to the stage of the disease.
Pezzilli R; Fabbri D; Imbrogno A; Morselli-Labate AM; Corinaldesi R
Pancreas; 2012 Aug; 41(6):976-8. PubMed ID: 22781914
[No Abstract] [Full Text] [Related]
17. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.
Zhang J; Wang YF; Wu B; Zhong ZX; Wang KX; Yang LQ; Wang YQ; Li YQ; Gao J; Li ZS
Curr Mol Med; 2017; 17(10):689-698. PubMed ID: 29521231
[TBL] [Abstract][Full Text] [Related]
18. Influence of age, gender and lifestyle in lymphocyte subsets: report from the Spanish Gait-2 Study.
García-Dabrio MC; Pujol-Moix N; Martinez-Perez A; Fontcuberta J; Souto JC; Soria JM; Nomdedéu JF
Acta Haematol; 2012; 127(4):244-9. PubMed ID: 22538526
[TBL] [Abstract][Full Text] [Related]
19. Quantitative abnormalities of peripheral blood distinct T, B, and natural killer cell subsets and clinical findings in obstetric antiphospholipid syndrome.
Carbone J; Gallego A; Lanio N; Navarro J; Orera M; Aguaron A; Fernandez-Cruz E; Sarmiento E
J Rheumatol; 2009 Jun; 36(6):1217-25. PubMed ID: 19332638
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]